Pending Challenges in Transradial Access

The recent SAFARI-STEMI study compared transradial and femoral access in patients with ST-segment elevation myocardial infarction, and no significant differences were found. These results have a sour taste for those in favor of transradial access, as they are convinced of its benefits and unwilling to go back to previous practices.

Desafíos pendientes con el acceso radial

This bitter taste is based on evidence rather than fanaticism; the SAFARI-STEMI should have conducted a more detailed analysis per treatment received, focusing on bleeding.

A good example comes from the RIVAL study: all major bleeding events in the radial arm were actually femoral complications. If this were also confirmed in SAFARI-STEMI, the importance of minimizing crossover would be clear.

Crossover from radial to femoral access occurred in 8.1% of patients in SAFARI-STEMI and in 7.6% in RIVAL. While this crossover rate is similar to what happens in daily clinical practice, its intent-to-treat analysis includes data that is hard to interpret.

Some measures can be taken to minimize crossover:

  • Failure in inserting the guidewire after a successful puncture is a fairly common issue. This may be due to tortuosity, puncture of a small side-branch, artery atherosclerosis or occlusion (in presence of a previous procedure). Solutions include inserting the guidewire using fluoroscopy and conducting a new puncture in a different place of the same artery—or in the contralateral artery.
  • Preventing spasms is another important issue. Using hydrophilic introducer sheaths, vasodilators, and small diameter catheters is helpful.
  • Careful insertion of catheters and guidewires is paramount. In case of sudden pain or resistance, the threshold to perform angiography should be very low. Some anatomical variants of the radial artery make the procedure difficult or impossible in about 15% of cases. Recognizing tortuosity, loops, or accessory radials helps to detect quick solutions.
  • Access can be moved from radial to contralateral or, in extreme circumstances, to transulnar. This was not specified in SAFARI-STEMI.

Read also: Intravascular Imaging: A Universal Approach for Angioplasty Optimization.


An important aspect in this particular group of patients—with ST-segment elevation myocardial infarction—is reperfusion time. Assuming that the time that an operator can take to deal with a challenging radial artery in these patients is much less than in stable patients is quite reasonable. Once again, we bring up the importance of a low threshold for radial angiography: the faster we know how is the radial artery we are dealing with, the faster the situation is solved—even if that means changing to a femoral artery.

Most femoral complications occur with operators who use transradial access almost exclusively (80-98%); consequently, being trained in both accesses is crucial.

Original Title: Residual Challenges in Radial Approach for Percutaneous Coronary Interventions.

Reference: Pierfrancesco Agostoni et al. JAMA Cardiol. 2020;5(12):1451-1452. doi:10.1001/jamacardio.2020.3730.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....